A Single-center, Single-dose, Double-blind, Randomized, Placebo- and Active-controlled Crossover Study to Evaluate the Abuse Potential of TC-5214 in Healthy Recreational Polydrug Users.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 21 Mar 2012
At a glance
- Drugs Dexmecamylamine; Ketamine; Phentermine
- Indications Anxiety disorders; Hypertension; Major depressive disorder; Obesity; Pain
- Focus Adverse reactions
- 21 Mar 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 30 Dec 2011 New trial record